Advanced RCC: Safety and Efficacy of IO/TKI Combination Therapies
Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.
Source: curetoday.com
Checkmate 9er News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Checkmate 9er. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Checkmate 9er Today - Breaking & Trending Today
Dr Tsao on the Role of Nivolumab Plus Cabozantinib in Advanced RCC
Che-Kai Tsao, MD, discusses key updates from the phase 3 CheckMate 9ER trial, and how these data clarify the role of nivolumab plus cabozantinib as a new standard of care in renal cell carcinoma.
Source: onclive.com
Front Line Trials in Advanced RCC
Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.
Source: onclive.com